<DOC>
	<DOCNO>NCT00599339</DOCNO>
	<brief_summary>This study conduct observational multiple-cohort design aim acquire clinical , treatment , health status , economic data . Patients Parkinson 's disease ( PD ) enrol .</brief_summary>
	<brief_title>Transdermal Rotigotine User Surveillance Study</brief_title>
	<detailed_description>All patient attend physician fulfilling eligibility criterion include .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Patients idiopathic earlystage Parkinson 's Disease require dopaminergic monotherapy ( rotigotine , dopamine agonist levodopa ) study onset Patients advancedstage Parkinson 's Disease require dopaminergic therapy levodopa combination rotigotine dopamine agonist study onset Patients unable comply study requirement</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Rotigotine</keyword>
	<keyword>Neupro</keyword>
</DOC>